AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
This article explains the main drivers of stock index performance and how various factors influence broad market moves. It helps readers understand signals behind daily swings and long-term trends.
20,153 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Casetlake LP has offered 6.90 per share in cash for EasyJet, valuing the airline around £5.2B, but investors remain d...
With American Express set to report on July 24, analysts say a durable franchise, disciplined capital returns, and a ...
Tesla beat market expectations with stronger-than-forecast Q4 results, sending shares higher as investors weigh the c...
This article breaks down pattern group (ptrn) 2025 earnings with a clear view of what to watch in the quarterly trans...
Constellation Energy has closed the Calpine deal and now commands the country’s largest private-sector power fleet, w...
Investors are weighing Amazon's retail muscle against cloud and AI competition. This guide asks: could amazon actuall...
A fund exited its Centerra Gold stake after a 150% rally, triggering talks of profit-taking and risk management. This...
Palantir shares moved higher as market chatter tied the AI and national security agenda to politics. Investors weigh ...
These tech titans just boosted their dividend payouts, catching income-focused investors by surprise. This guide brea...
Investors often ask if selling Tesla to invest in SpaceX could pay off. This guide breaks down the reality, the optio...
When a company’s top executive sells stock, investors want to know why. This deep dive explains BlackSky's sold over ...